C3 and glaucoma: Genetic deletion or pharmacological inhibition of C1q in animal models protects retinal ganglion cells, whereas C3 deletion worsens retinal ganglion cell survival [13, 29] reflecting the complex and time specific role of inflammation in glaucoma and the need for targeted therapies over broad anti-inflammatory strategies.